Always accessible, 24/7/365, US–based support and service for medical, product, and technical needs
Urgent deliveries of INOmax® (nitric oxide) gas, for inhalation, cylinders and INOmax Delivery Systems, most often within 4 to 6 hours*
*Emergency deliveries are most often made within 4 to 6 hours, but may take up to 24 hours, depending on hospital location and/or circumstances.
Regional Service Centers across the country to facilitate an emergency equipment response
Market-leading† bedside and transport delivery systems to help provide seamless transport of neonates and equipment in and between facilities1
†Based on December 2022 market share data.
A dependable inventory of INOmax Delivery Systems, INOmax cylinders, and consumables to support demand
Device-related trainings held live and virtually
‡Covers services included within your INOmax Total Care contract.
Your institution will receive our full service and support offering no matter which contract option you choose. Our contract options work for all types of NICUs. Connect with a representative to find a contract option that works best for your institution.
INOmax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Please see Full Prescribing Information.
Reference: 1. Data on File – Ref-06557. Mallinckrodt Pharmaceuticals.
INOmax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
INOmax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Please see Full Prescribing Information.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.